ATE497005T1 - Dna und spezifische proteine oder peptide der bakterienspezies neisseria meningitidis, verfahren zu deren herstellung und biologische anwendungen - Google Patents

Dna und spezifische proteine oder peptide der bakterienspezies neisseria meningitidis, verfahren zu deren herstellung und biologische anwendungen

Info

Publication number
ATE497005T1
ATE497005T1 AT97933727T AT97933727T ATE497005T1 AT E497005 T1 ATE497005 T1 AT E497005T1 AT 97933727 T AT97933727 T AT 97933727T AT 97933727 T AT97933727 T AT 97933727T AT E497005 T1 ATE497005 T1 AT E497005T1
Authority
AT
Austria
Prior art keywords
dna
neisseria meningitidis
peptides
production
bacterial species
Prior art date
Application number
AT97933727T
Other languages
English (en)
Inventor
Xavier Nassif
Colin Tinsley
Mark Achtman
Jean-Louis Ruelle
Carla Vinals
Petra Merker
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE497005T1 publication Critical patent/ATE497005T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT97933727T 1996-07-12 1997-07-11 Dna und spezifische proteine oder peptide der bakterienspezies neisseria meningitidis, verfahren zu deren herstellung und biologische anwendungen ATE497005T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9608768A FR2751000B1 (fr) 1996-07-12 1996-07-12 Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
PCT/FR1997/001295 WO1998002547A2 (fr) 1996-07-12 1997-07-11 Adn et proteines ou peptides specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques

Publications (1)

Publication Number Publication Date
ATE497005T1 true ATE497005T1 (de) 2011-02-15

Family

ID=9494012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97933727T ATE497005T1 (de) 1996-07-12 1997-07-11 Dna und spezifische proteine oder peptide der bakterienspezies neisseria meningitidis, verfahren zu deren herstellung und biologische anwendungen

Country Status (12)

Country Link
US (6) US7029845B2 (de)
EP (2) EP2138582B1 (de)
JP (3) JP2001504684A (de)
AT (1) ATE497005T1 (de)
AU (1) AU730423B2 (de)
CA (1) CA2260079C (de)
DE (1) DE69740110D1 (de)
ES (1) ES2365110T3 (de)
FR (1) FR2751000B1 (de)
HK (1) HK1024927A1 (de)
PT (1) PT951552E (de)
WO (1) WO1998002547A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751000B1 (fr) 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
ES2333071T5 (es) 1998-01-14 2015-08-17 Novartis Vaccines And Diagnostics S.R.L. Antígenos de Neisseria meningitidis
GB9808734D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
ES2294629T3 (es) * 1998-05-01 2008-04-01 Novartis Vaccines And Diagnostics, Inc. Antigenos de neisseria y composiciones.
GB9811260D0 (en) 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel compounds
GB9820003D0 (en) 1998-09-14 1998-11-04 Smithkline Beecham Biolog Novel compounds
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
AU2289000A (en) * 1999-01-15 2000-08-01 Smithkline Beecham Biologicals (Sa) (neisseria meningitidis) polypeptide basb052
WO2000042191A2 (en) * 1999-01-15 2000-07-20 Smithkline Beecham Biologicals S.A. Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
CA2359492A1 (en) * 1999-01-15 2000-07-20 Smithkline Beecham Biologicals S.A. Neisseria meningitidis antigen
AU2439300A (en) * 1999-01-22 2000-08-07 Smithkline Beecham Biologicals (Sa) Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof
WO2000043518A1 (en) * 1999-01-22 2000-07-27 Smithkline Beecham Biologicals S.A. Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
CA2360667A1 (en) 1999-01-22 2000-07-27 Smithkline Beecham Biologicals S.A. Neisseria meningitidis basb054 polypeptides and encoding polynucleotides and uses thereof
GB9902070D0 (en) * 1999-01-29 1999-03-24 Smithkline Beecham Biolog Novel compounds
PT1163343E (pt) 1999-03-12 2010-02-23 Glaxosmithkline Biolog Sa Polipéptidos antigénicos de neisseria meningitidis, polinucleótidos e anticorpos protectores correspondentes
GB9916529D0 (en) 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
EP2275551B1 (de) * 1999-10-29 2015-04-08 Novartis Vaccines and Diagnostics S.r.l. Antigenpeptide aus Neisseria
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use
BRPI0112928B1 (pt) 2000-07-27 2017-08-29 Children's Hospital & Research Center At Oakland A composition comprising preparations comprising outer membrane vesicles (OMV), microvesicles (MV) or both MVO and MV
US7250172B2 (en) 2001-01-31 2007-07-31 University Of Iowa Research Foundation Vaccine and compositions for the prevention and treatment of neisserial infections
US7261901B2 (en) 2001-01-31 2007-08-28 University Of Iowa Research Foundation Vaccine and compositions for the prevention and treatment of neisserial infections
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
GB0103424D0 (en) * 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
JP4740738B2 (ja) 2002-08-02 2011-08-03 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
CN1809380B (zh) 2002-10-11 2010-05-12 启龙有限公司 广泛防御高毒性脑膜炎球菌谱系的多肽-疫苗
LT1556477T (lt) 2002-11-01 2017-10-25 Glaxosmithkline Biologicals S.A. Džiovinimo būdas
ATE474595T1 (de) 2003-10-02 2010-08-15 Glaxosmithkline Biolog Sa B. pertussis antigene und ihre verwendung bei der vakzinierung
EP2433647A3 (de) 2005-01-27 2012-06-06 Children's Hospital & Research Center at Oakland Gna1870-basierte vesikelimpfstoffe für breitbandschutz gegen neisseria meningitidis-bedingte erkrankungen
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
JP5275983B2 (ja) 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
US20130004530A1 (en) 2010-03-10 2013-01-03 Jan Poolman Vaccine composition
EP2635593B1 (de) * 2010-11-05 2016-09-14 Institut National de la Sante et de la Recherche Medicale (INSERM) Impfstoffe zur verhinderung von meningokokken-infektionen
CN104736563A (zh) 2012-07-27 2015-06-24 国家健康与医学研究院 Cd147作为受体用于脑膜炎球菌至血管内皮的菌毛介导的粘附

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS1106A7 (is) 1959-06-29 1959-07-08 C. Van Der Lely N.V. Tæki til að flytja til hliðar uppskeru, sem liggur á jörðinni
CA1339871C (en) * 1986-11-24 1998-05-19 Richard Dana Smith Nucleic acid probes for detection and/or quantitation of non-viral organisms
JPH01125328A (ja) * 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
EP0337896B1 (de) * 1988-04-15 1993-07-28 N.V. Innogenetics S.A. Hybridisationssonden zum Nachweis von Neisseria-Stämme
WO1990015621A1 (en) * 1989-06-19 1990-12-27 Statens Seruminstitut A malaria vaccine
EP0452596A1 (de) * 1990-04-18 1991-10-23 N.V. Innogenetics S.A. Hibridizierungssonden aus dem Abstandsbereich zwischen den 16S- und 23S-rRNA-Genen und Nachweis von nichtviralen Mikroorganismen
US6086896A (en) * 1990-07-16 2000-07-11 Imclone Systems Incorporated Antigenic iron repressible protein from N. meningitidis related to the hemolysin family of toxins
ES2152933T3 (es) * 1991-10-23 2001-02-16 Baylor College Medicine Determinacion de huellas relativas a cepas bacterianas utilizando amplificacion de secuencias de adn repetitivas.
DE69222013T2 (de) 1991-12-16 1998-01-29 Ciba Geigy Ag Endoplasmatisches Retikulum-ständige rekombinante dibasische Endoprotease und deren Verwendungen
AU5093693A (en) * 1992-08-31 1994-03-29 Global Tek, Inc. Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis
US5445933A (en) * 1992-09-15 1995-08-29 Boehringer Mannheim Corporation Strand displacement assay and complex useful therefor
CA2145653A1 (en) 1992-09-30 1994-04-14 Herbert S. Aldwinckle Transgenic pomaceous fruit with fire blight resistance
US5436142A (en) * 1992-11-12 1995-07-25 Cold Spring Harbor Laboratory Methods for producing probes capable of distingushing variant genomic sequences
US6401267B1 (en) * 1993-09-27 2002-06-11 Radoje Drmanac Methods and compositions for efficient nucleic acid sequencing
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US5698438A (en) * 1994-10-18 1997-12-16 Oregon Health Sciences University Bacterial hemoglobin receptor gene
AU700952B2 (en) * 1995-06-07 1999-01-14 Pioneer Hi-Bred International, Inc. PCR-based cDNA subtractive cloning method
US5747252A (en) * 1995-06-07 1998-05-05 Gen-Probe Incorporated Nucleic acid probes and amplification oligonucleotides for Neisseria species
US6277382B1 (en) * 1995-10-17 2001-08-21 Oregon Health Sciences University Hemoglobin receptors from neisseriae
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
ES2333071T5 (es) * 1998-01-14 2015-08-17 Novartis Vaccines And Diagnostics S.R.L. Antígenos de Neisseria meningitidis
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria

Also Published As

Publication number Publication date
US20070105225A1 (en) 2007-05-10
EP2138582A3 (de) 2010-05-05
EP0951552B1 (de) 2011-01-26
US20020164603A1 (en) 2002-11-07
US20110313026A1 (en) 2011-12-22
AU730423B2 (en) 2001-03-08
US20090305275A1 (en) 2009-12-10
FR2751000A1 (fr) 1998-01-16
US20060063167A1 (en) 2006-03-23
ES2365110T3 (es) 2011-09-22
JP2001504684A (ja) 2001-04-10
EP0951552A2 (de) 1999-10-27
HK1024927A1 (en) 2000-10-27
AU3697797A (en) 1998-02-09
US8357791B2 (en) 2013-01-22
WO1998002547A3 (fr) 1998-04-09
FR2751000B1 (fr) 1998-10-30
PT951552E (pt) 2011-05-24
DE69740110D1 (de) 2011-03-10
US7368556B2 (en) 2008-05-06
EP2138582B1 (de) 2015-04-08
WO1998002547A2 (fr) 1998-01-22
US20070082361A1 (en) 2007-04-12
JP2009291218A (ja) 2009-12-17
CA2260079C (fr) 2013-05-14
CA2260079A1 (fr) 1998-01-22
EP2138582A2 (de) 2009-12-30
JP2009022296A (ja) 2009-02-05
US7029845B2 (en) 2006-04-18

Similar Documents

Publication Publication Date Title
ATE497005T1 (de) Dna und spezifische proteine oder peptide der bakterienspezies neisseria meningitidis, verfahren zu deren herstellung und biologische anwendungen
EP2275551A3 (de) Antigenpeptide aus Neisseria
PT1626985E (pt) Gera??o de prote?nas de liga??o artificiais ? base da prote?na ubiquitina
CA2438080A1 (en) Gonococcal proteins and nucleic acids
BR9914374A (pt) Sequências genÈmicas de neisseria e métodos para seu uso
HUP0301659A2 (hu) Kukorica cellulóz-szintetázok és alkalmazásuk
ATE476508T1 (de) Neisseriale antigene
BR9814276A (pt) Antìgenos de superfìcie
WO2001072976A3 (en) 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor
DE60041981D1 (de) Neisseria meningitidis-serumgruppen b und c-antigene sowie ein zusätzliches antigen enthaltende zusammensetzungen
BR0213774A (pt) Molécula de ácido nucleio isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
HUP0203221A2 (hu) A lignin bioszintézisében résztvevő enzimeket kódoló gének és alkalmazásuk
WO2004081033A3 (en) Synthesis of proteins by cell-free protein expression
DK0629238T3 (da) Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi
AU2002320301A1 (en) Novel pgc-1 isoforms and uses therefor
WO2003070768A3 (en) Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof
Bankowski et al. Human procollagen: I. An anionic tropocollagen precursor from skin fibroblasts in culture
ATE548468T1 (de) Für bakterielle antigene spezifische nukleinsäuremoleküle und ihre verwendung
AU2001280639A1 (en) 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor
WO2001079489A8 (en) 39228, a human alcohol dehydrogenase and uses therefor
DE502004008729D1 (de) Gegen das Prothrombin-Fragment F1+2 gerichtete Antikörper, ihre Herstellung und Verwendung
Ruelius et al. Poricin, an acidic protein with antitumor activity from a Basidiomycete: I. Production, isolation, and purification
WO2002044366A3 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
AU2347501A (en) Trp-protein-related mtr1 protein and dna sequence coding therefor
CN108218970A (zh) 一种重组蛋白及其制备方法和应用

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0951552

Country of ref document: EP